Wayne H H Sheu
Overview
Explore the profile of Wayne H H Sheu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki K, Hatzikotoulas K, Southam L, Taylor H, Yin X, Lorenz K, et al.
Nature
. 2024 Feb;
627(8003):347-357.
PMID: 38374256
Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes and molecular mechanisms that are often specific to cell type. Here, to characterize the genetic contribution...
2.
Suzuki K, Hatzikotoulas K, Southam L, Taylor H, Yin X, Lorenz K, et al.
medRxiv
. 2023 Apr;
PMID: 37034649
Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes. To characterise the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study...
3.
Lim L, Lau E, Kong A, Fu A, Lau V, Jia W, et al.
Lancet Reg Health West Pac
. 2023 Feb;
32:100663.
PMID: 36785858
Background: In Asia, diabetes-associated death due to cardiorenal diseases were 2-3 times higher in women than men which might be due to gender disparity in quality of care and health...
4.
Branch K, Dagenais G, Avezum A, Basile J, Conget I, Cushman W, et al.
Eur J Heart Fail
. 2022 Sep;
24(10):1805-1812.
PMID: 36073143
Aims: People with diabetes are at high risk for cardiovascular events including heart failure (HF). We examined the effect of the glucagon-like peptide 1 agonist dulaglutide on incident HF events...
5.
Cheung J, Lau E, Tsui C, Siu E, Tse N, Hui N, et al.
BMC Med
. 2022 Jul;
20(1):249.
PMID: 35831899
Background: Family history (FamH) of type 2 diabetes might indicate shared genotypes, environments, and/or behaviors. We hypothesize that FamH interacts with unhealthy behaviors to increase the risk of early onset...
6.
Mahajan A, Spracklen C, Zhang W, Ng M, Petty L, Kitajima H, et al.
Nat Genet
. 2022 May;
54(5):560-572.
PMID: 35551307
We assembled an ancestrally diverse collection of genome-wide association studies (GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non-European descent) through the Diabetes Meta-Analysis...
7.
Lim L, Lau E, Fu A, Ray S, Hung Y, Tan A, et al.
JAMA Netw Open
. 2021 Apr;
4(4):e217557.
PMID: 33929522
Importance: Many health care systems lack the efficiency, preparedness, or resources needed to address the increasing number of patients with type 2 diabetes, especially in low- and middle-income countries. Objective:...
8.
Fahed A, Aragam K, Hindy G, Chen Y, Chaudhary K, Dobbyn A, et al.
Circ Genom Precis Med
. 2020 Dec;
14(1):e003092.
PMID: 33284643
No abstract available.
9.
Dagenais G, Ryden L, Leiter L, Lakshmanan M, Dyal L, Probstfield J, et al.
Cardiovasc Diabetol
. 2020 Nov;
19(1):199.
PMID: 33239067
Background: The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) double blind randomized trial demonstrated that weekly subcutaneous dulaglutide 1.5 mg, a glucagon like peptide-1 receptor agonist, versus...
10.
Ji L, Chan J, Yu M, Yoon K, Kim S, Choi S, et al.
Diabetes Obes Metab
. 2020 Sep;
23(1):3-17.
PMID: 32991073
Type 2 diabetes (T2D) in the East Asian population is characterized by phenotypes such as low body mass index, an index of β-cell dysfunction, and higher percentage of body fat,...